Delivery Order SPE2DB24D1201-SPE2DB25FJCTU
Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,253.34 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in a 30-count unit quantity. The contract utilizes firm fixed price pricing with no set-aside designation and is scheduled for completion by May 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small-value...
- The Defense Logistics Agency awarded a delivery order valued at $43,857.85 to AmerisourceBergen Drug Corp for DELSTRIGO 100-300-300 mg tablets (30-count units) with a firm fixed price structure. The contract was competitively awarded without any set-aside designation and is scheduled for completion by November 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,086.70 to AmerisourceBergen Drug Corp for Delstrigo 100-300-300 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of December 24, 2025, represents a non-competitive, non-set-aside procurement issued on December 23, 2025. The award is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global...
- The Defense Logistics Agency awarded a delivery order valued at $13,460.59 to AmerisourceBergen Drug Corp for DELSTRIGO (100-300-300 mg tablets), a fixed-price pharmaceutical delivery with an ultimate completion date of November 14, 2025. This competitively awarded, non-set-aside order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in a 30-count unit package. This competitively awarded, non-set-aside delivery order has a ceiling value of $10,080.18 and a firm fixed price structure, with an ultimate completion date of May 9, 2025. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. Delstrigo is an antiretroviral...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DELSTRIGO 100-300-300 MG TAB UU 30S, a specialty pharmaceutical product. The contract has a completion date of January 29, 2024 and a potential value of $17,807.95. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,944,624 units of the pharmaceutical product DELSTRIGO 100-300-300 MG TAB UU 30S. The contract has a firm fixed price of $37,530.36 and a period of performance through April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,570.02 firm fixed-price delivery order is for the supply of DELSTRIGO 100-300-300 MG TAB UU 30S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $26,109.77 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,388.63 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, represents a non-competitive, non-set-aside award executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...